Charity BreakdownCanadian charity filings, itemized

Westman Prostate Cancer Support Group

Charitable organization · Brandon, Manitoba · BN 874453210RR0001 · Core Health Care

Your $100, itemizedWestman Prostate Cancer Support GroupFiscal year ended December 31, 2024
Charitable programs$100
TOTAL$100
Registered

Source: T3010 return, FPE 2024-12-31. Split of total expenditures ($117) as filed with the CRA.

Westman Prostate Cancer Support Group is a charitable organization based in Brandon, Manitoba, classified by the CRA under core health care. In its fiscal year ending December 31, 2024, it reported $400 in revenue and $117 in expenditures.

Its funding that year was roughly 19% from other charities. In 2022, 1 other registered charity reported granting it a combined $86.

Its reserves, measured in years of spending on hand, sat in the top decile of the group.

Revenue has declined over its filings on record here, from $1,245 in 2020 to $400 in 2024. Its filed list of directors and trustees shows 1 name.

In its own words

Providing support education information and awareness for cancer patients and their families through guest speakers audio and visual programmes on topics and treatments plus other related health problems.

Ongoing-program description from its T3010 filing, verbatim.

The ledger, 20202024

YearRevenueSpendingProgramsFundraisingGifts outNet assets
2024$400$117$3,819
2023$86$81$3,536
2022$37$76$3,536
2021$24$76$76$3,575
2020$1,245$209$209$3,627

Revenue printed in red where the year ran a deficit. Fiscal years by period end.

Money between charities, 2022

Received $86 from 1 charity:

As reported on the donors’ own T3010 qualified-donee schedules.

Directors & trustees (2024)

Donald Partrick (chair/treasurer).

As listed on its 2024 return.

Check the source

Every figure on this page is from Westman Prostate Cancer Support Group’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 874453210RR0001), or read how we compute the receipt.